Early diagnosis of melanoma skin cancer using an app that harnesses space technology developed by GMV is the aim of the DALEM project. The Biomedical Research Foundation of Madrid’s Hospital Universitario La Paz (FIBHULP) has set up the DALEM project with GMV, focusing on providing technological means for monitoring pigmented skin lesions.

Using our cell phone camera, we can record the skin map of any moles to be monitored to see their morphology, characteristics, particularities, and changes over time. These images, reviewed by a dermatologist, will be the basis for making a diagnosis as early as possible, which is of inestimable value, especially in patients susceptible to developing a malignant pigmented lesion such as melanoma. This advance in medicine, combined with digital technology, will help to establish early diagnoses and will undoubtedly facilitate the follow-up process, something that until now could only be achieved through face-to-face consultations.

The transfer of navigation technology to dermatology has a number of benefits for patients, including:

• Early diagnosis of malignant pigmented lesions such as melanoma and the consequent reduction in mortality;
• Personalized patient follow-up, bridging the gap between the work of dermatologists during face-to-face consultations and their follow-up on possible changes in the skin;
• Tracking moles (pigmented lesions) easily and over time; and
• Monitoring when new pigmented lesions appear.

Benefits of transferring GMV’s space technology to dermatology

GMV has become the sixth largest industrial group and the first mid-cap in the European space industry, with over 1,300 people working in this area. It is the world's leading provider of control centers for commercial satellite operators. Highlights include the contract it won to upgrade and maintain the Galileo ground control system. The various divisions of the company leverage shared knowledge, transferring it from one area to another. In this particular case, space developments are applied to the field of health.

Taking part in the project are doctors Ander Paulo Mayor Ibarguren, Marta Feito Rodríguez, Fátima Albizuri Prado, and Rosa Feltes Ochoa, all of whom are specialists in medical and surgical dermatology and venereology at the Hospital Universitario La Paz. They agree that, as Feltes pointed out, “The advance that this technology could represent over existing systems for identifying and monitoring pigmented lesions in images could be very significant. None of the applications currently available on the market provide a means of detecting new moles or changes in existing moles over time. Hence, a safe and automatic method is needed to ascertain whether or not there are changes in the skin before the next follow-up appointment. In addition, the recording of images at different times and with an acceptable level of robustness can be very useful in the necessary monitoring leading up to the diagnosis of pathologies with an oncological profile, such as melanoma.”